Health Canada Approves VENCLEXTA® in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia Biotech Investing
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 Biotech Investing
Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications Support Biotech Investing
BELLUS Health Announces First Patient Dosed in its Phase 2 BLUEPRINT Trial of BLU-5937 for the Treatment of Chronic Pruritus Associated with Atopic Dermatitis Biotech Investing
CHMP Recommends the Approvals of RINVOQ for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic® for Adult Patients with Newly Diagnosed and Previously Treated Myelofibrosis Biotech Investing
Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID® with Cipla Biotech Investing
Gilead Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast Cancer Biotech Investing
RINVOQ Achieved Superiority Versus DUPIXENT® For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis Biotech Investing
